Malassezia sympodialis differently affects the expression of LL-37 in dendritic cells from atopic eczema patients and healthy individuals

Allergy
B AgerberthA Scheynius

Abstract

Atopic eczema (AE) is a multifactorial disease, which has increased in prevalence. The skin-colonizing yeast Malasezzia sympodialis can induce IgE- and T-cell reactivity in patients with AE. LL-37 is an endogenous peptide antibiotic belonging to the cathelicidin family. The aim of this study was to examine whether exposure to M. sympodialis would affect the expression of LL-37 in dendritic cells. The presence of LL-37 was analyzed in monocyte-derived dendritic cells (MDDCs) generated from healthy individuals and patients with AE by Western blotting and the corresponding cDNA by real-time quantitative RT-PCR. Antibacterial activity was measured with an inhibition zone assay in fractions after reverse phase chromatography. For the first time we here present data, showing that LL-37 is produced by MDDCs. Notably, the secretion of LL-37 was substantially enhanced in M. sympodialis-exposed MDDCs generated from patients with a high degree of eczema, as measured by SCORAD, compared to healthy controls and patients with a low SCORAD. The relative expression of LL-37 transcript in MDDCs generated from patients was up-regulated after 1 h of exposure to M. sympodialis and declined gradually at the time points analyzed, whereas the transcr...Continue Reading

References

Jul 1, 1994·The Journal of Experimental Medicine·N RomaniG Schuler
Jan 1, 1993·Dermatology : International Journal for Clinical and Investigative Dermatology
Dec 1, 1995·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·A ZargariA Scheynius
Mar 7, 1998·The Journal of Biological Chemistry·J JohanssonB Agerberth
Jul 3, 1999·American Journal of Respiratory and Critical Care Medicine·B AgerberthG H Gudmundsson
Dec 21, 2000·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·E BuentkeA Scheynius
Oct 27, 2001·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·E BuentkeA Scheynius
Jan 25, 2002·Nature·Michael Zasloff
Apr 20, 2002·Science·Maria YazdanbakhshRonald van Ree
Apr 30, 2002·International Archives of Allergy and Immunology·Annika ScheyniusMaria Tengvall Linder
Sep 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Monisha G ScottRobert E W Hancock
Oct 11, 2002·The New England Journal of Medicine·Peck Y OngDonald Y M Leung
Mar 26, 2003·The British Journal of Dermatology·C JohanssonM Tengvall Linder
Sep 10, 2003·Journal of Leukocyte Biology·Margherita Zanetti
Sep 17, 2003·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Eva Buentke, Annika Scheynius
Jan 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Donald J DavidsonDavid P Speert
Mar 10, 2004·Springer Seminars in Immunopathology·G A W RookL Rosa Brunet
Jun 5, 2004·International Archives of Allergy and Immunology·Francesca GranucciPaola Ricciardi-Castagnoli
Jun 15, 2005·Cellular Microbiology·Peter BergmanBirgitta Agerberth

❮ Previous
Next ❯

Citations

May 19, 2007·Medical Mycology·H R Ashbee
Jan 11, 2012·Clinical Microbiology Reviews·Georgios GaitanisAristea Velegraki
Nov 26, 2009·Natural Product Reports·Matthew F Burton, Patrick G Steel
Apr 13, 2010·Autoimmunity·Liam O'MahonyCezmi A Akdis
Jun 29, 2013·Clinics in Dermatology·Georgios GaitanisIoannis D Bassukas
Oct 26, 2020·Medical Mycology·Wafa RhimiClaudia Cafarchia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.